CLOSED

GET A PIECE OF 20/20 GENESYSTEMS

Diagnostic Testing for COVID-19 & Cancer

This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Company Image